In Features this morning the Labor policy maven explains the not big benefits and roll-call of risks in the Government’s proposed innovation incentive

The government plans to reduce the tax rate on patent income to 17 per cent, for biotech companies at first. This, warns Senator Carr, creates “an incentive for multinational companies to move their intellectual property around between jurisdictions.”

A much better way to create incentives for Australian manufacturers is to improve the Research and Development Tax Incentive, as discussed (and do not tell CMM you did not see this coming) in the Review of the Three Fs.